Atrial fibrillation: strategies to control, combat, and cure.
about
Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A reviewThermal strain imaging: a reviewRole of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility.Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.Cardiovascular magnetic resonance imaging of scar development following pulmonary vein isolation: a prospective study.Paroxysmal atrial fibrillation developed during incomplete epidural anesthesia -A case report-.Functional dominant-negative mutation of sodium channel subunit gene SCN3B associated with atrial fibrillation in a Chinese GeneID populationGenome-wide linkage scan identifies a novel genetic locus on chromosome 5p13 for neonatal atrial fibrillation associated with sudden death and variable cardiomyopathy.Role of echocardiography in atrial fibrillation.The feasibility of using thermal strain imaging to regulate energy delivery during intracardiac radio-frequency ablation.The role of echocardiography in atrial fibrillation and cardioversion.Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion.Impact of hemodialysis on P-wave amplitude, duration, and dispersion.Postoperative arrhythmias in general surgical patients.Ablation for atrial fibrillation: an evidence-based analysisAcute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits.Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillationA review of the literature on atrial fibrillation: rate reversion or control?Evaluation of cardiac emboli source.Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleedAntithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cNovel molecular targets for atrial fibrillation therapy.Role of cardiac computed tomography and cardiovascular magnetic resonance imaging in guiding management and treatment of patients with atrial fibrillation: state of the art review.Atrial fibrillation: to map or not to map?Dynamics and modulation studies of human voltage gated Kv1.5 channel.Prescribing patterns and outcomes of enoxaparin for anticoagulation of atrial fibrillation.Influence of Cheyne-Stokes respiration on ventricular response to atrial fibrillation in heart failure.Relationship between connexins and atrial activation during human atrial fibrillation.Prospectively ECG-triggered sequential dual-source coronary CT angiography in patients with atrial fibrillation: comparison with retrospectively ECG-gated helical CT.
P2860
Q26827939-3137800B-032B-46E5-B840-9133451F1250Q30464922-242FA7F8-83DA-4169-9C89-B74AFBC00A85Q33286816-8A98BD65-E6D0-4DCC-9123-805FB2A42F54Q33572627-93C553FD-BA23-4B14-99A9-7FC638288BB0Q33631107-5D4B0B8D-E985-4407-8BC5-F09C8EAC570FQ34241060-1229A626-23BF-4237-9C4D-35A47ADE7167Q34535493-DE95DB35-08E1-4B15-8676-98EA803F1E5BQ35093111-CF2429D3-F711-4405-9598-B349ADE8F73DQ35104048-E72CF548-5157-43E9-BB49-F10099585A0AQ35148789-6AF09A9D-89FA-4E2C-9072-C6991EBB344BQ35224972-7D1F12A6-4721-4244-A6AB-ABD9565B3753Q35583778-891084A3-AF47-4160-8565-6327DEF78B27Q35588997-5ADD73BD-C7AC-4151-8725-15FDE44BDE07Q35812404-C8FEAC2C-2F34-4819-BD77-EDFA5EB223E5Q35971004-F32C7B9A-7C15-4B15-B8D6-ED16458E9ED7Q36046946-C58F68D9-88CD-40AE-A8B7-9AFFA647C669Q36216795-7EC28A90-10AD-43FD-9BAF-A6033A6F3D85Q36513612-8FA320CC-88F3-48F8-BF41-9D6DABB69D9BQ36689259-72A9789B-A9A9-4B57-8303-A85A0F51387EQ36813398-9E380886-650E-4AA5-843C-C51F088CFB95Q36924488-68E7BA1D-4306-4B95-832A-32F55DAE19A9Q37222361-9638C3AF-0986-467E-A2B3-D5DC2FA7B361Q37998312-003F8183-FDBA-48B1-9CCF-CFD8F00713ADQ38080752-605C259F-8910-44B2-9A95-D0BD9DC98361Q38152975-B4DE2FF9-52E9-42F0-A091-CEBB42522178Q38918724-9C44602C-FD81-436B-82B1-0641B3E63784Q44437063-EB95F6E5-C920-4C15-A77D-E818615A4CD5Q47770579-71F4553A-30AD-454F-9B5F-A914EADAD348Q47933334-39A2D85E-4216-45C3-846F-43278C37AC2FQ53110466-4FF35B66-24F3-4824-A0E2-A55F09E72328
P2860
Atrial fibrillation: strategies to control, combat, and cure.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Atrial fibrillation: strategies to control, combat, and cure.
@ast
Atrial fibrillation: strategies to control, combat, and cure.
@en
Atrial fibrillation: strategies to control, combat, and cure.
@nl
type
label
Atrial fibrillation: strategies to control, combat, and cure.
@ast
Atrial fibrillation: strategies to control, combat, and cure.
@en
Atrial fibrillation: strategies to control, combat, and cure.
@nl
prefLabel
Atrial fibrillation: strategies to control, combat, and cure.
@ast
Atrial fibrillation: strategies to control, combat, and cure.
@en
Atrial fibrillation: strategies to control, combat, and cure.
@nl
P2093
P1433
P1476
Atrial fibrillation: strategies to control, combat, and cure.
@en
P2093
Nicholas S Peters
Prapa Kanagaratnam
Richard J Schilling
Vias Markides
P304
P356
10.1016/S0140-6736(02)07748-6
P407
P577
2002-02-01T00:00:00Z